Literature DB >> 20443821

Integrating bioethics into clinical and translational science research: a roadmap.

Robyn S Shapiro1, Peter M Layde.   

Abstract

Recent initiatives to improve human health emphasize the need to effectively and appropriately translate new knowledge gleaned from basic biomedical and behavioral research to clinical and community application. To maximize the beneficial impact of scientific advances in clinical practice and community health, and to guard against potential deleterious medical and societal consequences of such advances, incorporation of bioethics at each stage of clinical and translational science research is essential. At the earliest stage, bioethics input is critical to address issues such as whether to limit certain areas of scientific inquiry. Subsequently, bioethics input is important to assure not only that human subjects trials are conducted and reported responsibly, but also that results are incorporated into clinical and community practices in a way that promotes and protects bioethical principles. At the final stage of clinical and translational science research, bioethics helps to identify the need and approach for refining clinical practices when safety or other concerns arise. The framework we present depicts how bioethics interfaces with each stage of clinical and translational science research, and suggests an important research agenda for systematically and comprehensively assuring bioethics input into clinical and translational science initiatives.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20443821      PMCID: PMC5439590          DOI: 10.1111/j.1752-8062.2008.00005.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  7 in total

1.  A national survey of policies on disclosure of conflicts of interest in biomedical research.

Authors:  S V McCrary; C B Anderson; J Jakovljevic; T Khan; L B McCullough; N P Wray; B A Brody
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Conflict-of-interest policies for investigators in clinical trials.

Authors:  B Lo; L E Wolf; A Berkeley
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  In whose best interest? Breaching the academic-industrial wall.

Authors:  J B Martin; D L Kasper
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Policies on faculty conflicts of interest at US universities.

Authors:  M K Cho; R Shohara; A Schissel; D Rennie
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

5.  An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial.

Authors:  Ken Kipnis; Nancy M P King; Robert M Nelson
Journal:  Am J Bioeth       Date:  2006 May-Jun       Impact factor: 11.229

6.  Rules is rules.

Authors:  Robert D Orr
Journal:  Am J Bioeth       Date:  2006 May-Jun       Impact factor: 11.229

7.  In defense of the PolyHeme trial.

Authors:  Anne Hamilton Dougherty
Journal:  Am J Bioeth       Date:  2006 Sep-Oct       Impact factor: 11.229

  7 in total
  5 in total

1.  Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide.

Authors:  Susan M Wolf; Wylie Burke; Barbara A Koenig
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

2.  Creating a Research Ethics Consultation Service: Issues to Consider.

Authors:  Holly A Taylor; Kathryn M Porter; Erin Talati Paquette; Jennifer B McCormick; Emma Tumilty; Jason F Arnold; Kayte Spector-Bagdady; Marion Danis; Debra Brandt; Jina Shah; Benjamin S Wilfond; Lisa M Lee
Journal:  Ethics Hum Res       Date:  2021-09

3.  Advancing medical technology innovation and clinical translation via a model of industry-enabled technical and educational support: Indiana Clinical and Translational Sciences Institute's Medical Technology Advance Program.

Authors:  Andrew O Brightman; R Lane Coffee; Kara Garcia; Aaron E Lottes; Thomas G Sors; Sharon M Moe; George R Wodicka
Journal:  J Clin Transl Sci       Date:  2021-01-19

Review 4.  Values in translation: how asking the right questions can move translational science toward greater health impact.

Authors:  Maureen Kelley; Kelly Edwards; Helene Starks; Stephanie M Fullerton; Rosalina James; Sara Goering; Suzanne Holland; Mary L Disis; Wylie Burke
Journal:  Clin Transl Sci       Date:  2012-08-07       Impact factor: 4.689

Review 5.  Translational research-the need of a new bioethics approach.

Authors:  Sorin Hostiuc; Alin Moldoveanu; Maria-Iuliana Dascălu; Runar Unnthorsson; Ómar I Jóhannesson; Ioan Marcus
Journal:  J Transl Med       Date:  2016-01-15       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.